Beclin-1-Dependent Autophagy Protects the Heart During Sepsis

Yuxiao Sun, Xiao Yao, Qing Jun Zhang, Min Zhu, Zhi Ping Liu, Bo Ci, Yang Xie, Deborah Carlson, Beverly A. Rothermel, Yuxiang Sun, Beth Levine, Joseph A. Hill, Steven Wolf, Joseph P. Minei, Qun S. Zang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

BACKGROUND: Cardiac dysfunction is a major component of sepsis-induced multiorgan failure in critical care units. Changes in cardiac autophagy and its role during sepsis pathogenesis have not been clearly defined. Targeted autophagy-based therapeutic approaches for sepsis are not yet developed. METHODS: Beclin-1-dependent autophagy in the heart during sepsis and the potential therapeutic benefit of targeting this pathway were investigated in a mouse model of lipopolysaccharide (LPS)-induced sepsis. RESULTS: LPS induced a dose-dependent increase in autophagy at low doses, followed by a decline that was in conjunction with mammalian target of rapamycin activation at high doses. Cardiac-specific overexpression of Beclin-1 promoted autophagy, suppressed mammalian target of rapamycin signaling, improved cardiac function, and alleviated inflammation and fibrosis after LPS challenge. Haplosufficiency for beclin 1 resulted in opposite effects. Beclin-1 also protected mitochondria, reduced the release of mitochondrial danger-associated molecular patterns, and promoted mitophagy via PTEN-induced putative kinase 1-Parkin but not adaptor proteins in response to LPS. Injection of a cell-permeable Tat-Beclin-1 peptide to activate autophagy improved cardiac function, attenuated inflammation, and rescued the phenotypes caused by beclin 1 deficiency in LPS-challenged mice. CONCLUSIONS: These results suggest that Beclin-1 protects the heart during sepsis and that the targeted induction of Beclin-1 signaling may have important therapeutic potential.

Original languageEnglish (US)
Pages (from-to)2247-2262
Number of pages16
JournalCirculation
Volume138
Issue number20
DOIs
StatePublished - Nov 13 2018
Externally publishedYes

Fingerprint

Autophagy
Sepsis
Lipopolysaccharides
Sirolimus
Mitochondrial Degradation
Inflammation
Beclin-1
Critical Care
Mitochondria
Fibrosis
Therapeutics
Phenotype
Peptides
Injections

Keywords

  • autophagy
  • Beclin-1
  • heart failure
  • mitochondrial degradation
  • sepsis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Sun, Y., Yao, X., Zhang, Q. J., Zhu, M., Liu, Z. P., Ci, B., ... Zang, Q. S. (2018). Beclin-1-Dependent Autophagy Protects the Heart During Sepsis. Circulation, 138(20), 2247-2262. https://doi.org/10.1161/CIRCULATIONAHA.117.032821

Beclin-1-Dependent Autophagy Protects the Heart During Sepsis. / Sun, Yuxiao; Yao, Xiao; Zhang, Qing Jun; Zhu, Min; Liu, Zhi Ping; Ci, Bo; Xie, Yang; Carlson, Deborah; Rothermel, Beverly A.; Sun, Yuxiang; Levine, Beth; Hill, Joseph A.; Wolf, Steven; Minei, Joseph P.; Zang, Qun S.

In: Circulation, Vol. 138, No. 20, 13.11.2018, p. 2247-2262.

Research output: Contribution to journalArticle

Sun, Y, Yao, X, Zhang, QJ, Zhu, M, Liu, ZP, Ci, B, Xie, Y, Carlson, D, Rothermel, BA, Sun, Y, Levine, B, Hill, JA, Wolf, S, Minei, JP & Zang, QS 2018, 'Beclin-1-Dependent Autophagy Protects the Heart During Sepsis', Circulation, vol. 138, no. 20, pp. 2247-2262. https://doi.org/10.1161/CIRCULATIONAHA.117.032821
Sun Y, Yao X, Zhang QJ, Zhu M, Liu ZP, Ci B et al. Beclin-1-Dependent Autophagy Protects the Heart During Sepsis. Circulation. 2018 Nov 13;138(20):2247-2262. https://doi.org/10.1161/CIRCULATIONAHA.117.032821
Sun, Yuxiao ; Yao, Xiao ; Zhang, Qing Jun ; Zhu, Min ; Liu, Zhi Ping ; Ci, Bo ; Xie, Yang ; Carlson, Deborah ; Rothermel, Beverly A. ; Sun, Yuxiang ; Levine, Beth ; Hill, Joseph A. ; Wolf, Steven ; Minei, Joseph P. ; Zang, Qun S. / Beclin-1-Dependent Autophagy Protects the Heart During Sepsis. In: Circulation. 2018 ; Vol. 138, No. 20. pp. 2247-2262.
@article{c0924b8fea7148cba733e254518f958f,
title = "Beclin-1-Dependent Autophagy Protects the Heart During Sepsis",
abstract = "BACKGROUND: Cardiac dysfunction is a major component of sepsis-induced multiorgan failure in critical care units. Changes in cardiac autophagy and its role during sepsis pathogenesis have not been clearly defined. Targeted autophagy-based therapeutic approaches for sepsis are not yet developed. METHODS: Beclin-1-dependent autophagy in the heart during sepsis and the potential therapeutic benefit of targeting this pathway were investigated in a mouse model of lipopolysaccharide (LPS)-induced sepsis. RESULTS: LPS induced a dose-dependent increase in autophagy at low doses, followed by a decline that was in conjunction with mammalian target of rapamycin activation at high doses. Cardiac-specific overexpression of Beclin-1 promoted autophagy, suppressed mammalian target of rapamycin signaling, improved cardiac function, and alleviated inflammation and fibrosis after LPS challenge. Haplosufficiency for beclin 1 resulted in opposite effects. Beclin-1 also protected mitochondria, reduced the release of mitochondrial danger-associated molecular patterns, and promoted mitophagy via PTEN-induced putative kinase 1-Parkin but not adaptor proteins in response to LPS. Injection of a cell-permeable Tat-Beclin-1 peptide to activate autophagy improved cardiac function, attenuated inflammation, and rescued the phenotypes caused by beclin 1 deficiency in LPS-challenged mice. CONCLUSIONS: These results suggest that Beclin-1 protects the heart during sepsis and that the targeted induction of Beclin-1 signaling may have important therapeutic potential.",
keywords = "autophagy, Beclin-1, heart failure, mitochondrial degradation, sepsis",
author = "Yuxiao Sun and Xiao Yao and Zhang, {Qing Jun} and Min Zhu and Liu, {Zhi Ping} and Bo Ci and Yang Xie and Deborah Carlson and Rothermel, {Beverly A.} and Yuxiang Sun and Beth Levine and Hill, {Joseph A.} and Steven Wolf and Minei, {Joseph P.} and Zang, {Qun S.}",
year = "2018",
month = "11",
day = "13",
doi = "10.1161/CIRCULATIONAHA.117.032821",
language = "English (US)",
volume = "138",
pages = "2247--2262",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "20",

}

TY - JOUR

T1 - Beclin-1-Dependent Autophagy Protects the Heart During Sepsis

AU - Sun, Yuxiao

AU - Yao, Xiao

AU - Zhang, Qing Jun

AU - Zhu, Min

AU - Liu, Zhi Ping

AU - Ci, Bo

AU - Xie, Yang

AU - Carlson, Deborah

AU - Rothermel, Beverly A.

AU - Sun, Yuxiang

AU - Levine, Beth

AU - Hill, Joseph A.

AU - Wolf, Steven

AU - Minei, Joseph P.

AU - Zang, Qun S.

PY - 2018/11/13

Y1 - 2018/11/13

N2 - BACKGROUND: Cardiac dysfunction is a major component of sepsis-induced multiorgan failure in critical care units. Changes in cardiac autophagy and its role during sepsis pathogenesis have not been clearly defined. Targeted autophagy-based therapeutic approaches for sepsis are not yet developed. METHODS: Beclin-1-dependent autophagy in the heart during sepsis and the potential therapeutic benefit of targeting this pathway were investigated in a mouse model of lipopolysaccharide (LPS)-induced sepsis. RESULTS: LPS induced a dose-dependent increase in autophagy at low doses, followed by a decline that was in conjunction with mammalian target of rapamycin activation at high doses. Cardiac-specific overexpression of Beclin-1 promoted autophagy, suppressed mammalian target of rapamycin signaling, improved cardiac function, and alleviated inflammation and fibrosis after LPS challenge. Haplosufficiency for beclin 1 resulted in opposite effects. Beclin-1 also protected mitochondria, reduced the release of mitochondrial danger-associated molecular patterns, and promoted mitophagy via PTEN-induced putative kinase 1-Parkin but not adaptor proteins in response to LPS. Injection of a cell-permeable Tat-Beclin-1 peptide to activate autophagy improved cardiac function, attenuated inflammation, and rescued the phenotypes caused by beclin 1 deficiency in LPS-challenged mice. CONCLUSIONS: These results suggest that Beclin-1 protects the heart during sepsis and that the targeted induction of Beclin-1 signaling may have important therapeutic potential.

AB - BACKGROUND: Cardiac dysfunction is a major component of sepsis-induced multiorgan failure in critical care units. Changes in cardiac autophagy and its role during sepsis pathogenesis have not been clearly defined. Targeted autophagy-based therapeutic approaches for sepsis are not yet developed. METHODS: Beclin-1-dependent autophagy in the heart during sepsis and the potential therapeutic benefit of targeting this pathway were investigated in a mouse model of lipopolysaccharide (LPS)-induced sepsis. RESULTS: LPS induced a dose-dependent increase in autophagy at low doses, followed by a decline that was in conjunction with mammalian target of rapamycin activation at high doses. Cardiac-specific overexpression of Beclin-1 promoted autophagy, suppressed mammalian target of rapamycin signaling, improved cardiac function, and alleviated inflammation and fibrosis after LPS challenge. Haplosufficiency for beclin 1 resulted in opposite effects. Beclin-1 also protected mitochondria, reduced the release of mitochondrial danger-associated molecular patterns, and promoted mitophagy via PTEN-induced putative kinase 1-Parkin but not adaptor proteins in response to LPS. Injection of a cell-permeable Tat-Beclin-1 peptide to activate autophagy improved cardiac function, attenuated inflammation, and rescued the phenotypes caused by beclin 1 deficiency in LPS-challenged mice. CONCLUSIONS: These results suggest that Beclin-1 protects the heart during sepsis and that the targeted induction of Beclin-1 signaling may have important therapeutic potential.

KW - autophagy

KW - Beclin-1

KW - heart failure

KW - mitochondrial degradation

KW - sepsis

UR - http://www.scopus.com/inward/record.url?scp=85056463995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056463995&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.117.032821

DO - 10.1161/CIRCULATIONAHA.117.032821

M3 - Article

C2 - 29853517

AN - SCOPUS:85056463995

VL - 138

SP - 2247

EP - 2262

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 20

ER -